Showing results (301-310 of 357) with videos related to

Sort By:
Pageof 36
AIDS (London, England)|April 14, 2011
Efficacy of NNRTI-based antiretroviral therapy initiated during acute HIV infectionCynthia L Gay, Ashley J Mayo, Chelu K Mfalila, et al.
Open Forum Infectious Diseases|May 20, 2025
Dolutegravir/Abacavir/Lamivudine in Acute HIV-1 Results in Rapid Suppression and Restoration of CD4 T-cell Subsets Without Accelerated Decay of Latent HIV-1Cynthia L Gay, Jessica Keys, JoAnn D Kuruc, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 31, 2012
Immediate antiviral therapy appears to restrict resting CD4+ cell HIV-1 infection without accelerating the decay of latent infectionNancie M Archin, Naveen K Vaidya, Joann D Kuruc, et al.
The Journal of Infectious Diseases|February 5, 2009
Regimen simplification to atazanavir-ritonavir alone as maintenance antiretroviral therapy: final 48-week clinical and virologic outcomesTimothy J Wilkin, John E McKinnon, A Gregory DiRienzo, et al.
Cell Reports. Medicine|November 10, 2023
Dominant CD4+ T cell receptors remain stable throughout antiretroviral therapy-mediated immune restoration in people with HIVAlexis Sponaugle, Ann Marie K Weideman, Jolene Ranek, et al.
Biorxiv : the Preprint Server for Biology|April 17, 2026
The ENL-USP7 Complex Regulates HIV Latency Through BRD4 StabilizationWaqas Ahmed, Xiaoyi Li, Ciniso S Shabangu, et al.
Science Translational Medicine|October 11, 2019
The replication-competent HIV-1 latent reservoir is primarily established near the time of therapy initiationMelissa-Rose Abrahams, Sarah B Joseph, Nigel Garrett, et al.
Molecular Therapy. Methods & Clinical Development|September 20, 2019
HIV-Specific T Cell Responses Are Highly Stable on Antiretroviral TherapyYinyan Xu, Ilana M Trumble, Joanna A Warren, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 19, 2008
Detection of nonnucleoside reverse-transcriptase inhibitor-resistant HIV-1 after discontinuation of virologically suppressive antiretroviral therapyC Bradley Hare, John Mellors, Amy Krambrink, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 26, 2018
HIV-Specific, Ex Vivo Expanded T Cell Therapy: Feasibility, Safety, and Efficacy in ART-Suppressed HIV-Infected IndividualsJulia A Sung, Shabnum Patel, Matthew L Clohosey, et al.
Pageof 36